The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study

Authors :: Liposits, G.
Skuladottir, H.
Ryg, J.
Winther, S. B.
Möller, S.
Hofsli, E.
Shah, C-H.
Oestergaard, L. Poulsen
Berglund, A.
Qvortrup, C.
Osterlund, P. J.
Johansen, J. S.
Glimelius, B.
Sorbye, H.
Pfeiffer, P.
Source :: Liposits, G, Skuladottir, H, Ryg, J, Winther, S B, Möller, S, Hofsli, E, Shah, C-H, Oestergaard, L P, Berglund, A, Qvortrup, C, Osterlund, P J, Johansen, J S, Glimelius, B, Sorbye, H & Pfeiffer, P 2022, ' The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study ', Annals of Oncology, vol. 33, no. Suppl. 7, 345P, pp. S694 . https://doi.org/10.1016/j.annonc.2022.07.483
Publication Year :: 2022

Language :: English
Database :: OpenAIRE
Journal :: Liposits, G, Skuladottir, H, Ryg, J, Winther, S B, Möller, S, Hofsli, E, Shah, C-H, Oestergaard, L P, Berglund, A, Qvortrup, C, Osterlund, P J, Johansen, J S, Glimelius, B, Sorbye, H & Pfeiffer, P 2022, ' The prognostic value of pre-treatment circulating biomarkers of systemic inflammation (CRP, neutrophil-to-lymphocyte ratio, IL-6, and YKL-40) in vulnerable older patients with metastatic colorectal cancer: The randomized NORDIC9-study ', Annals of Oncology, vol. 33, no. Suppl. 7, 345P, pp. S694 . https://doi.org/10.1016/j.annonc.2022.07.483
Accession number :: edsair.dedup.wf.001..bc612cb7a51fc0a38da5d0bca9a6cf73

Tools